FGFR2-Driven Signaling Counteracts Tamoxifen Effect on ERα-Positive Breast Cancer Cells

Signaling mediated by growth factors receptors has long been suggested as one of the key factors responsible for failure of endocrine treatment in breast cancer (BCa). Herein we present that in the presence of tamoxifen, FGFs (Fibroblast Growth Factors) promote BCa cell growth with the strongest eff...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Neoplasia
Päätekijät: Turczyk, Lukasz, Kitowska, Kamila, Mieszkowska, Magdalena, Mieczkowski, Kamil, Czaplinska, Dominika, Piasecka, Dominika, Kordek, Radzisław, Skladanowski, Andrzej C., Potemski, Piotr, Romanska, Hanna M., Sadej, Rafal
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Neoplasia Press 2017
Aiheet:
Original article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5964976/
https://ncbi.nlm.nih.gov/pubmed/28869838
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neo.2017.07.006
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia